The NAT study asked people
with HIV to complete an online survey about their experience, during the previous six
months, of five symptoms
commonly associated with HIV: fatigue, anxiety or depression, insomnia,
gastro-intestinal problems and neuropathy (nerve pain). There was space to mention other symptoms too.
It is not surprising that
in a study inviting people to self-report, the majority of the 265 respondents
had at least one of the symptoms on the list. The most common was fatigue,
suffered by 57%, followed by depression or anxiety (55%), gastro-intestinal (GI)
problems (48%), insomnia (46%) and neuropathy (33%).
More significant was the
fact that more people experienced these symptoms as fluctuating rather than
constant. Respondents described conditions as ‘constant’ with frequencies
ranging from about 38% in insomnia to 24% in the case of GI problems, but as ‘varying
over time’ with frequencies ranging from 53% in fatigue to 31% with neuropathy.
Fatigue was mentioned as a
particularly common and troubling symptom. Very few respondents could usually predict when fatigue would hit them. One commented that “When I have it
I am quite incapacitated and have no choice but to limit, stop or cancel plans
to do things.” Another said “it is always there, lurking...if I do anything for
more than an hour it begins to kick in.” One respondent managed to hold down a
job but always required a nap of one to two hours immediately after coming
home. Although 40% of respondents thought a combination of HIV and HIV medications
caused their fatigue, 30% said they really had ‘no idea’ what caused it.
Depression and anxiety were
nearly as common as fatigue, though respondents did not say they affected work
so much. The main feature of these were their frequency: 90% of respondents
said they had experienced either or both at some point in the last month. Given that a third of respondents said that bouts of depression or anxiety
lasted more than a week at a time, many people must be living with severely
disordered mood a lot of the time.
Diarrhoea, nausea and other
GI problems were the symptoms most likely to be linked in people’s minds to HIV
treatment. Thirty per cent of respondents thought these were the exclusive cause
of their problems and 45% thought HIV and HIV treatments were both to blame. The
frequency of bouts of diarrhoea varied from once to more than five times a
month.
Insomnia and poor sleep,
especially chronic, not only impacts on quality of life: it is a cause of significant
physical and psychological illness. Although this has been associated with HIV
drugs, especially efavirenz, 45% of respondents did not know why their sleep
was so poor. Sleeplessness was very unpredictable – people would be fine one
night and not the next. Forty-three per cent said having problems sleeping
could last for more than a week. When insomnia is this prolonged, memory, mood
and cognitive function can be severely affected. One respondent said sleep
problems meant “I am unable to focus on my work, feeling like I have jet lag.”
Neuropathy (nerve pain) was
the least-experienced of the conditions but was still suffered by a third
of respondents. About equal numbers of people attributed it to HIV itself and
to HIV drugs. In some cases the pain of neuropathy was constant – one person
said his feet were always sore and this prevented standing or walking for more
than 15 minutes. But the majority said that while some symptoms such as
numbness were always there others, such as stabbing pains, were unpredictable and
often severe.
Most respondents suffered
from multiple symptoms: for instance, of those with depression or anxiety, 75%
also had fatigue and 57% insomnia; of those with neuropathy, 61% had fatigue
and 68% GI problems.
About 40% of respondents
were unemployed, with a higher proportion among those reporting GI problems or
fluctuating neuropathy. There was a generally positive attitude to work, with
one respondent happy to have just started a job after 18 months of unemployment
– “I am knackered but happy to be working,” s/he said.
In other cases however it
was clear that fluctuating symptoms were significantly affecting people’s
ability or willingness to work. One question asked “on how many occasions in
the past four weeks have your symptoms significantly affected your ability to
work”? A quarter of people with fatigue, 20% with neuropathy, and about 15% of
those with depression and GI problems reported that this had happened more than five times in the past four weeks.
One respondent asked: “How
do you work round this kind of thing unless you work for yourself or for an
extremely understanding employer?”